64
Views
18
CrossRef citations to date
0
Altmetric
Miscellaneous

Sex hormones and chronic headache in women

Pages 1839-1848 | Published online: 24 Feb 2005

Bibliography

  • LABBE EE, MURPHY L, O'BRIEN C: Psychosocial factors and the prediction of headache in college students. Headache (1997) 37:1–5.
  • CELENTANO DD, LINET MS, STEWART WF: Gender differences in the experience of headache. Soc. ScL Med. (1990) 30:1289–1295.
  • LINET MS, CELENTANO DD, STEWART WF: Headache characteristics associated with physician consultation: a population-based survey. Am. j Prey Med. (1991) 7:40–46.
  • ROKICKI LA, HOLROYD KA: Factors influencing treatment-seeking behavior in problem headache sufferers. Headache (1994) 34:429–434.
  • ZEICHNER A, LOFTIN M, G et al: Sex differences in pain indices, exercise, and use of analgesics. Psycho] Rep. (2000) 86:129–133.
  • UNRUH AM: Gender variations in clinical pain experience. Pain (1996) 65:123–167.
  • UNRUH AM, RITCHIE J, MERSKEY H: Does gender affect appraisal of pain and pain coping strategies? arr. j Pain (1999) 15:31–40.
  • HELLSTROM B, LUNDBERG U: Pain perception to the cold pressor test during the menstrual cycle in relation to estrogen levels and a comparison with men. Integr Physial Behav. Sci. (2000) 35:1377–1379.
  • COYLE DE, SELHORST CS, BEHBEHANI MM: Intact female rats are more susceptible to the development of tactile allodynia than ovariectomised female rats following partial sciatic nerve ligation (PSNL). Neurosci. Lett. (1996) 206:37–40.
  • SEGARRA AC, MCEWEN BS: Estrogen increases spine density in ventromedial hypothalamic neurones of peripubertal rats. Neumencloccindogy (1991) 54:365–372.
  • •Important basic science study demonstrating cyclical morphologic changes within neurones following exposure to oestradiol. Demonstration of cyclical production and destruction of new synapses highlights neural plasticity in relation to sex hormones.
  • AMANDUSSON A, HERMANSON 0, BLOMQVIST A: Colocalization of oestrogen receptor immunoreactivity and mRNA expression to neurones in the superficial laminae of the spinal and medullary dorsal horn of rats. Eur j Neuresci. (1996) 8:2440–2445.
  • AMANDUSSON A, HALLBECK M, HALLBECK AL et al.: Oestrogen-induced alterations of spinal cord enkephalin gene expression. Pain (1999) 83:243–248.
  • •A direct relationship between oestrogen and pain modulators is demonstrated.
  • JOY KP, THARAKAN B, GOOS HJ: Distribution of gamma-aminobutyric acid in catfish (Heteropneustes fossilis) forebrain in relation to season, ovariectomy and E2 replacement, and effects of GABA administration on plasma gonadotropin-II level. Comp. Biochem. Physial A. Mal Integr: Physial (1999) 123:369–376.
  • LAGRANGE AH, RONNEKLEIV OK, KELLY MJ: The potency of mu-opioid hyperpolarization of hypothalamic arcuate neurones is rapidly attenuated by 17-beta-estradiol. j Neuresci. (1994) 14:6196–6204.
  • MARCUS DA: Interrelationships of neurochemicals, oestrogen, and recurring headache. Pain (1995) 62:129–139.
  • •Review article describing relationships between oestrogen and a variety of neurotransmitters important for the pathogenesis of chronic headache.
  • DAWSON-BASOA MB, GINTZLER AR: 17-Beta-estradiol and progesterone modulate an intrinsic opioid analgesic system. Brain. Res. (1993) 601:241–245.
  • •A relationship between oestradiol levels and pain threshold is demonstrated in rodents undergoing simulated pregnancy.
  • COGAN R, SPINNATO JA: Pain and discomfort thresholds in late pregnancy. Pain (1986) 27:63–68.
  • MOSKOWITZ MA: The neurobiology of vascular head pain. Ann. Neural. (1984) 16:157–168.
  • ••Development of the neurovascular modelof migraine.
  • MARCUS DA: Serotonin and its role in pathogenesis and treatment. Clirr. J Pain. (1993) 9:159–167.
  • •This review article develops simplified models of 5-HT in relation to headache and a variety of clinical situations that alter headache activity.
  • KRUGER H, LUHMANN HJ, HEINEMANN U: Repetitive spreading depression causes selective suppression of GABAergic function. Neurareport. (1996) 7:2733–2736.
  • FANCIULLACI M, ALESSANDRI M, DEL ROSSO A: Dopamine involvement in the migraine attack. Fund-. Neural. (2000) 15:171–181.
  • LACOSTE A, MALHAM SK, CUEFF A,POULET SA: Stress-induced catecholamine changes in the hemolymph of the oyster Crassostrea gigas. Gen. Comp. Endocrine]. (2001) 122:181–188.
  • ANTHONY M, HINTERBERGER H, LANCE JW: Plasma serotonin in migraine and stress. Arch. Neural. (1967) 16:544–552.
  • ROLF LH, WIELE G, BRUNE GG: 5-hydroxytryptamine in platelets of patients with muscle contraction headache. Headache (1981) 21:10–11.
  • KIMBALL RW, FRIEDMAN AE VALLEJO E: Effect of serotonin in migraine patients. Neurology (1960) 10:107–111.
  • LANCE JW, LAMBERT GA, GOADSBY PJ, ZERGANI AS: 5-Hydroxytryptophan and its putative aetiological involvement in migraine. Cephalalgia (1989) 9\(Suppl. 9):7–13.
  • MATHEW RC, HO BT, KRALIK P, CLAGHORN JL: Biochemical basis for biofeedback treatment of migraine: a hypothesis. Headache (1979) 19:290–293.
  • GONZALES GF, CARRILLO C: Blood serotonin levels in postmenopausal women: effects of age and serum oestradiol levels. Maturitas (1993) 17:23–29.
  • CALHOUN AH: Adjusting oestradiol concentrations reduces headache frequency and severity in female migraineurs. Cephalalgia (2001) 21:449–449.
  • MARTIN PL, BURNIER AM, SEGRE EJ, HUIX FJ: Graded sequential therapy in menopause: a double-blind study. Am. Obstet. Cymru]. (1971) 3:178–186.
  • KUDROW L: The relationship of headache frequency to hormone use in migraine. Headache (1975) 15:36–40.
  • MACGREGOR A: Estrogen replacement and migraine with aura. Headache (1999) 39:674–678.
  • EDWARDS HE, BURNHAM WM: Steroid hormones affect limbic afterdischarge thresholds and kindling rates in adult female rats. Brain Res. (1999) 838:136–150.
  • SABERI M, POURGHOLAMI MH, JORJANI M: The acute effects of estradiol benzoate on amygdala-kindled seizures in male rats. Brain Res. (2001) 891:1–6.
  • YITZHAKY J, FRENK H, URCA G: Kindling-induced changes in morphine analgesia and catalepsy: evidence for independent opioid systems. Brain Res. (1982) 237:193–201.
  • SCAER RC: The neurophysiology of dissociation and chronic disease. App. Psychaphysial Biofeedback (2001) 26:73–91.
  • PAGNI CA: The origin of tic douloureaux: a unified view. j. Neurosurg. Sci. (1993) 37:185–194.
  • POST RM, SILBERSTEIN SD: Shared mechanism in affective illness, epilepsy, and migraine. Neurology (1994) 44(10 Suppl. 7):S37–S47.
  • DALSGAARD-NIELSEN T: Some aspects of the epidemiology of migraine in Denmark. Headache (1970) 10:14–23.
  • BILLE B: A 40-year follow-up of school children with migraine. Cephalalgia (1997) 17:488–491.
  • ••A long-term prospective, longitudinalstudy following children with migraine through to adulthood.
  • ABU-AREFEH I, RUSSELL G: Prevalence of headache and migraine in schoolchildren. Br Med. J. (1994) 309:765–769.
  • WOBER-BINGOL C, WOBER C, WAGNER-ENNSGRABER C et al.: IHS criteria and gender: a study on migraine and tension-type headache in children and adolescents. Cephalalgia (1996) 16:107–112.
  • SILLANPAA M: Changes in the prevalenceof migraine and other headaches during the first seven school years. Headache (1983) 23:15–19.
  • SILLANPAA M, PIEKKALA P: Prevalenceof migraine and other headaches in early puberty. Scandj Prim. Health Care (1984) 2:27–32.
  • SOLBACH P, SARGENT J, COYNE L et al.: Tension headache: a comparison of menstrual and non-menstrual occurrences. Headache. (1988) 28:108–110.
  • SCHARFF L, TURK DC, MARCUS DA: Triggers of headache episodes and coping responses of headache diagnostic groups. Headache (1995) 35:397–403.
  • RASMUSSEN BK: Migraine and tension-type headache in a general population: precipitating factors, female hormones, sleep patterns and relation to life. Pain (1993) 53:65–72.
  • •Epidemiological study noting changes in both migraine and tension-type headache in women throughout their life cycles.
  • AL-WAILI NS: Treatment of menstrual with prostaglandin synthesis inhibitor mefenamic acid: double-blind study with placebo. Eur. I Med. Res. (2000) 5:176–182.
  • BOYLE CA: Management of menstrual migraine. Neurololgy (1999) 53(4 Suppl. 1):S14–518.
  • D'ALESSANDRO R, GAMBERINI G, LOZITO A, SACQUEGHA T: Menstrual migraine: intermittent prophylaxis with a timed-release pharmacological formulation of dihydroergotamine. Cephalalgia (1983) 3\(Suppl. 1):156–158.
  • NEWMAN L, MANNIX LK, LANDY S et al.: Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study. Headache (2001) 41:248–256.
  • MURRAY S, MUSE K: Effective treatmentof severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and 'add-back' therapy. Fertz7. Sterll. (1997) 67:390–393.
  • HERZOG A: Continuous bromocriptinetherapy in menstrual migraine. Neurology (1997) 48:101–102.
  • LARSSON-COHN U, LUNDBERG PO: Headache and treatment with oral contraceptives. Acta Neural Land. (1970) 46:267–278.
  • PHILLIPS BM: Oral contraceptive drugs and migraine. Br Med. 1 (1968) 2:99.
  • WHITTY CM, HOCKADAY JM: Migraine: a follow-up study of 92 patients. Br Med. J. (1968) 1:735–736.
  • KUDROW L: The relationship of headache frequency to hormone use in migraine. Headache (1975) 15:36–40.
  • BECKER WJ: Migraine and oral contraceptive. Can. j. Neural Li. (1997) 24:16–21.
  • AKHTER H, DUNSON TR, AMATYA RN et al: A five-year clinical evaluation of Norplant contraceptive subdermal implants in Bangladeshi acceptors. Contraception (1993) 47:569–582.
  • MATSON SC, HENDERSON KA, MCGRATH GJ: Physical findings and symptoms of depot medroxyprogesterone acetate use in adolescent females. j. Pediatr. Adolesc. Grieco]. (1997) 10:18–23.
  • MACGREGOR EA, HACKSHAW A: Prevention of migraine in the pill-free week of combined oral contraceptives using natural °oestrogen supplements: a double- placebo-controlled study. Cephalalgia (2001) 21:449.
  • BECKER WJ: Use of oral contraceptives in patients with migraine. Neurology (1999) 53(4 Suppl. 1):519–525.
  • CALLAGHAN N: The migraine syndrome in pregnancy. Neurology (1968) 18:197–199.
  • GRANELLA F, SANCES G, C et al.: Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache (1993) 33:385–389.
  • CHEN TC, LEVITON A: Headache recurrences in pregnant women with migraine. Headache (1994) 34:107–110.
  • MAGGIONI E ALESSI C, MAGGINO T etal.: Primary headaches and pregnancy. Cephalalgia (1995) 15:54.
  • MARCUS DA, SCHARFF L, TURK DC: Longitudinal prospective study of headache during pregnancy and postpartum, Headache (1999) 39:625–632.
  • STEIN GS: Headaches in the first post partum week and their relationship to migraine. Headache (1981) 21:201–205.
  • STEIN GS, MORTON J, MARSHA et al: Headaches after childbirth. Acta Neural Scant/. (1984) 69:74–79.
  • MARCUS DA, SCHARFF L, TURK DC: Nonpharmacological management of headaches during pregnancy. Psychosomatic Medicine (1995) 57:527–535.
  • SCHARFF L, MARCUS DA, TURK DC: Maintenance of effects in the nonmedical treatment of headaches during pregnancy. Headache (1996) 36:285–290.
  • OLESEN L, STEFFENSEN FH, SORENSEN HT et al: Pregnancy outcome following prescription for sumatriptan. Headache (2000) 40:20–24.
  • KALLEN B, LYGNER PE: Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan. Headache. (2001) 41:351–356.
  • WEITZMAN RE, LEAKE RD, RUBIN RT, FISCHER DA: The effect of nursing on neurohypophyseal hormone and prolactin secretion in human subjects. j. Chi]. Endocrine]. Metab. (1980) 51:836–839.
  • AMICO JA, FINLEY BE: Breast stimulation in cycling women, pregnant women and a woman with induced lactation: pattern of release of oxytocin, and lutenising hormone. Clin. EridocnitoL (1986) 25:97–106.
  • ARLETTI R, BENELLI A, BERTOLINI A: Influence of oxytocin on nociception and morphine antinociception. Neuropeptides (1993); 24:125–129.
  • PETERSSON M, ALSTER P, T, UVNAS-MOBERG K: Oxytocin increases nociceptive thresholds in a long-term perspective in female and male rats. Neurosci. Lett. (1996) 212:87–90.
  • LUNDEBERG T, UVNAS-MOBERG K, AGREN G, BRUZELIUS G: Anti-nociceptive effects of oxytocin in rats and mice. Neurosci. Lett. (1994) 170:153–157.
  • UVNAS-MOBERG K, ALSTER E PETERSSON M et al.: Postnatal oxytocin injections cause sustained weight gain and increased nociceptive thresholds in male and female rats. Pediatr. Res. (1998) 43:344–348.
  • THURSTON CL, CULHANE ES, SUBERG SN et al.: Antinociceptive vs. motor effects of intrathecal vasopressin as measured by four pain tests. Brain Res. (1988) 463:1–11.
  • RAMASWAMY S, SHEWADE DG, TYAGI MG, BAPNA JS: Further studies on the anti-nociceptive effect of vasopressin. Pharm. PharnacoL (1992) 44:698–700.
  • LOBZIN VS, VASIEEV NS: Lechenie migreni vazopressinom. Zh. NevropatoL Psikhiatr. (1989) 1:54–58.
  • WALL VR: Breastfeeding and migraine headaches. J. Hum. Lact. (1992) 8:209–212.
  • NERI I, GRANELLA F, NAPPI R, MANZONI GC, FACCHINETTI GENAZZANI AR: Characteristics of headache at menopause: a clinico-epidemiologic study. Maturitas (1993) 17:31–37.
  • •Epidemiological study contrasting headache changes after menopause based on type of menopause and type of headache.
  • FRANCESCHI M, COLOMBO B, ROSSI P, CANAL N: Headache in a population-based elderly cohort. An ancillary study to the Italian Longitudinal Study of Aging (ILAS). Headache (1997) 37:79–82.
  • WANG SJ, LIU HC, FUH JL et al.: Prevalence of headaches in a Chinese elderly population in Kinmen: age and gender effect and cross-cultural comparison. Neurology (1997) 49:195–200.
  • MACGREGOR EA: 'Menstrual' migraine: towards a definition. Cephalalgia (1996) 16:11–21.
  • FACCHINETTI F, NAPPI RE, GRANELLA F et al.: Effects of hormone replacement treatment (HRT) in postmenopausal women with migraine. Cephalalgia (2001) 21:452.
  • AYLWARD M, HOLLY F, PARKER RJ: An evaluation of clinical response to piperazine oestrone sulphate (Harmogen') in patients. Curr. Med. Res. Opiri. (1974) 2:417–423
  • GREENBLATT RB. BRUNETEAU DW: Menopausal headache-Psychogenic or metabolic? j. Am. Geriatric Soc. (1974) 22:186–190.
  • SMITS MG, VAN DER MEER YG, PFEIL JP et al.: Pen-menstrual migraine: effect of Estraderm TTS and the value of contingent negative variation and exteroceptive temporalis muscle suppression test. Headache (1994) 34:103–106.
  • SCHOENEN J: Exteroceptive suppression of temporalis muscle activity: methodological and physiological aspects. Cephalalgia (1993) 13:3–10.
  • SCHOENEN J, BOTTIN D, SULON J, GASPARD U, LAMB OTTE R: Exteroceptive silent period of temporalis muscle in menstrual headaches. Cephalalgia (1991) 11:87–91.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.